These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32544294)

  • 1. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy.
    Booth S; Willan J; Wong H; Khan D; Farnell R; Hunter A; Eyre T; Katz H; Dungarwalla M; Chen L; Browning J; Polzella P; Gray N; Neelakantan P; Dhillon EK; Dutton D; Sternberg A; Prideaux S; Collins GP; Peniket A
    Eur J Haematol; 2020 Oct; 105(4):476-483. PubMed ID: 32544294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
    Glenthøj A; Jakobsen LH; Sengeløv H; Ahmad SA; Qvist K; Rewes A; Poulsen CB; Overgaard UM; Mølle I; Severinsen MT; Strandholdt CN; Maibom J; Kodahl AR; Ryg J; Ravn P; Johansen IS; Helsø SN; Jensen-Fangel S; Kisielewicz J; Wiese L; Helleberg M; Kirk O; Clausen MR; Frederiksen H
    Eur J Haematol; 2021 Jan; 106(1):72-81. PubMed ID: 32939853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
    Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
    Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 in persons with haematological cancers.
    He W; Chen L; Chen L; Yuan G; Fang Y; Chen W; Wu D; Liang B; Lu X; Ma Y; Li L; Wang H; Chen Z; Li Q; Gale RP
    Leukemia; 2020 Jun; 34(6):1637-1645. PubMed ID: 32332856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
    Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
    Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
    Civriz Bozdağ S; Cengiz Seval G; Yönal Hindilerden İ; Hindilerden F; Andıç N; Baydar M; Aydın Kaynar L; Toprak SK; Göksoy HS; Balık Aydın B; Demirci U; Can F; Özkocaman V; Gündüz E; Güven ZT; Özkurt ZN; Demircioğlu S; Beksaç M; İnce İ; Yılmaz U; Eroğlu Küçükdiler H; Abishov E; Yavuz B; Ataş Ü; Mutlu YG; Baş V; Özkalemkaş F; Üsküdar Teke H; Gürsoy V; Çelik S; Çiftçiler R; Yağcı M; Topçuoğlu P; Çeneli Ö; Abbasov H; Selim C; Ar MC; Yücel OK; Sadri S; Albayrak C; Demir AM; Güler N; Keklik M; Terzi H; Doğan A; Yegin ZA; Kurt Yüksel M; Sadri S; Yavaşoğlu İ; Beköz HS; Aksu T; Maral S; Erol V; Kaynar L; İlhan O; Bolaman AZ; Sevindik ÖG; Akyay A; Özcan M; Gürman G; Ünal Ş; Yavuz Y; Diz Küçükkaya R; Özsan GH
    Turk J Haematol; 2022 Feb; 39(1):43-54. PubMed ID: 34521187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.
    Lund LC; Rahbek MT; Brown P; Obel N; Hallas J; Frederiksen H
    Eur J Haematol; 2023 Dec; 111(6):946-950. PubMed ID: 37740535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study.
    Oliva A; Curtolo A; Volpicelli L; Cancelli F; Borrazzo C; Cogliati Dezza F; Marcelli G; Gavaruzzi F; Di Bari S; Ricci P; Turriziani O; Mastroianni CM; Venditti M
    Infection; 2022 Oct; 50(5):1373-1382. PubMed ID: 35781785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
    Bhogal T; Khan UT; Lee R; Stockdale A; Hesford C; Potti-Dhananjaya V; Jathanna A; Rahman S; Tivey A; Shotton R; Sundar R; Valerio C; Norouzi A; Walker P; Suckling R; Armstrong A; Brearton G; Pettitt A; Kalakonda N; Palmer DH; Jackson R; Turtle L; Palmieri C
    Leuk Lymphoma; 2021 Jul; 62(7):1682-1691. PubMed ID: 33508995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 in patients with hematologic malignancy.
    Langerbeins P; Hallek M
    Blood; 2022 Jul; 140(3):236-252. PubMed ID: 35544585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
    Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
    Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date.
    El-Sharkawi D; Iyengar S
    Br J Haematol; 2020 Aug; 190(3):336-345. PubMed ID: 32559308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in respiratory infection trends during the COVID-19 pandemic in patients with haematologic malignancy.
    Ryoo J; Kim SC; Lee J
    BMC Pulm Med; 2024 May; 24(1):259. PubMed ID: 38797852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.
    Shah V; Ko Ko T; Zuckerman M; Vidler J; Sharif S; Mehra V; Gandhi S; Kuhnl A; Yallop D; Avenoso D; Rice C; Sanderson R; Sarma A; Marsh J; de Lavallade H; Krishnamurthy P; Patten P; Benjamin R; Potter V; Ceesay MM; Mufti GJ; Norton S; Pagliuca A; Galloway J; Kulasekararaj AG
    Br J Haematol; 2020 Sep; 190(5):e279-e282. PubMed ID: 32526039
    [No Abstract]   [Full Text] [Related]  

  • 18. Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy.
    Booth S; Curley HM; Varnai C; Arnold R; Lee LYW; Campton NA; Cook G; Purshouse K; Aries J; Innes A; Cook LB; Tomkins O; Oram HS; Tilby M; Kulasekararaj A; Wrench D; Dolly S; Newsom-Davies T; Pettengell R; Gault A; Moody S; Mittal S; Altohami M; Tillet T; Illingworth J; Mukherjee L; Apperly J; Ashcroft J; Rabin N; Carmichael J; Cazier JB; Kerr R; Middleton G; Collins GP; Palles C;
    Br J Haematol; 2022 Feb; 196(4):892-901. PubMed ID: 34761389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies.
    Martín-Moro F; Marquet J; Piris M; Michael BM; Sáez AJ; Corona M; Jiménez C; Astibia B; García I; Rodríguez E; García-Hoz C; Fortún-Abete J; Herrera P; López-Jiménez J
    Br J Haematol; 2020 Jul; 190(1):e16-e20. PubMed ID: 32379921
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.